Congress Presentations

Stay informed about the latest scientific and medical research from Axsome.

Filter

Sort

American Association of Psychiatric Pharmacists (AAPP) 2026

Seattle, WA | April 19 - 22, 2026

Alzheimer’s Disease Agitation

Real-World Treatment Patterns and Clinical Management of Alzheimer’s Disease Agitation

View / Download

AXS-05 | Major Depressive Disorder

Anxiolytic Effects of Dextromethorphan-Bupropion (45mg/105mg): Post Hoc Analyses Across Trials in Major Depressive Disorder

View / Download

AXS-05 | Major Depressive Disorder

Real-World Healthcare Utilization and Costs Associated With Using Dextromethorphan-Bupropion Extended-Release Tablets Versus Branded Comparators for the Treatment of Major Depressive Disorder

View / Download

This site contains scientific information about investigational compounds and/or information about products and/or uses that have not been approved by the US Food and Drug Administration. The safety and efficacy of investigational products and/or investigational uses of approved products has not been established and such investigational products/uses have not and may not be approved for marketing by any health authority.

AXSOME, AUVELITY, SUNOSI, SYMBRAVO and their logos are trademarks or registered trademarks of Axsome Therapeutics, Inc. or its affiliates. Other trademarks are property of their respective owners.